30 min. (RT) + 2 hours (RT) + 30 min. (RT) = 3 hours total incubation time
96 Determinations, 12x8 removable strips
2 controls, ready to use
Competitive immunoassay (ELISA) technique
FDA exempt, can be used for in-vitro diagnostics
The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
1,3,5(10)-estratriene-3,17β-diol; 17β-estradiol; E21
100 µL / determination
6 standards, ready to use
0 / 1 - 100 pg/mL
2 - 8 °C
This assay should not be used for patients being treated with the drug fulvestrant (Faslodex®) which cross-reacts in the assay and could lead to falsely elevated test results. See also information in the assay protocol.